Table 1 Treatment outcome of the 10 treated patients
Patient | Previous treatments yes/No | Type and number of previous treatments (Number) | Period of time in which lesion became inactive after LPC (number of treatment sessions) | Total time of follow up remaining inactive after reaching complete inactivation | Reactivation |
|---|---|---|---|---|---|
1 | No | 2 months (1) | 19 months | No | |
2 | Yes | Ranibizumab IV (4) | 7 months (2) | No more follow up | No |
3 | Yes | PDT (3), LPC (1) | 2 months (1) | 21 months | No |
4 | Yes | LPC (1), PDT (3), TTT (1), Ranibizumab IV(3) | 8 months (1) | 12 months | Yes (in the same area) |
5 | Yes | PDT (1), LPC (1) | 3 months (1) | 17 months | No |
6 | Yes | LPC (2), PDT (1) | 3 months (1) | No more follow up | No |
7 | Yes | Ranibizumab IV (2) | 7 months (1) | 23 months | Yes (in a different area) |
8 | No | 5 months (1) | 27 months | No | |
9 | Yes | TTT (1) | 3 months (1) | 12 months | No |
10 | Yes | PDT (1), Ranibizumab IV (1) | 3 months (1) | 9 months | No |